Vietnam Infectious Disease Therapeutics Market Analysis

Vietnam Infectious Disease Therapeutics Market Analysis


$ 3999

By 2030, it is anticipated that the Vietnam infectious disease therapeutics market will reach a value of $857.57 from $599.35 Mn in 2022, growing at a CAGR of 4.6% during 2022-2030. Infectious Disease Therapeutics in Vietnam is dominated by a few domestic pharmaceutical companies such as Hau Giang Pharmaceutical, Domesco Medical and OPC Pharmaceutical. The Infectious Disease Therapeutics market in Vietnam is segmented into different therapeutic areas and different diseases type. The major factors affecting the Vietnam infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious disease treatment in various areas of Vietnam.

ID: IN10VNPH038 CATEGORY: Pharmaceuticals GEOGRAPHY: Vietnam AUTHOR: Dr. Vishwa Modhia

Buy Now

Vietnam Infectious Disease Therapeutics Analysis Summary

By 2030, it is anticipated that the Vietnam infectious disease therapeutics market will reach a value of $857.57 from $599.35 Mn in 2022, growing at a CAGR of 4.6% during 2022-2030.

Vietnam is a low-middle-income, developing country located in Southeastern Asia bordering the Gulf of Thailand, the Gulf of Tonkin, and the South China Sea. Vietnam, according to the World Factbook, is particularly susceptible to infectious diseases. Food or waterborne infections include bacterial diarrhoea, hepatitis A, and typhoid fever. Dengue fever, malaria, and Japanese encephalitis are among vector-borne diseases that are common in Vietnam.

The Vietnamese government has been adopting a number of steps to alleviate the country's growing burden of infectious diseases. For example, the government has initiated a number of programmes to combat the spread of tuberculosis and dengue fever, including free diagnosis and treatment. Vietnam's government spends 4.7% of its GDP on healthcare.

Vietnam Infectious Disease Therapeutics Market Analysis

Market Dynamics

Market Growth Drivers Analysis

Tuberculosis is one of Vietnam's most frequent diseases. "Annually, it is projected that Vietnam has 17,000 TB deaths," according to USAID. Vietnam has a thriving economy with one of the region's fastest growth rates. Vietnam's large labour pool and inexpensive labour costs facilitate corporate expansion. These aspects could boost Vietnam's infectious disease therapeutics market.

Market Restraints

Access to some infectious disease medicines in Vietnam may be restricted by legislation such as prescribing limitations or prior authorisation requirements. This may have an effect on the demand for certain drugs and impede business growth. Shortcomings in Vietnam's business climate, fuelled by concerns about data transparency and corruption perceptions, can make doing business challenging. These factors may deter new entrants into the Vietnam infectious disease therapeutics market.

Competitive Landscape

Key Players

  • Hau Giang Pharmaceutical Joint Stock Company: Hau Giang Pharmaceutical is a pharmaceutical company based in Ho Chi Minh City, Vietnam. The company develops and manufactures drugs for various diseases, including infectious diseases
  • Vietnam Vaccine Joint Stock Company: Vietnam Vaccine is a state-owned company based in Hanoi, Vietnam. The company develops and manufactures vaccines for various diseases, including infectious diseases
  • Domesco Medical Import-Export Joint-Stock Corporation: Domesco Medical is a pharmaceutical company based in Ho Chi Minh City, Vietnam
  • Pymepharco Joint Stock Company: Pymepharco is a pharmaceutical company based in Ho Chi Minh City, Vietnam
  • OPC Pharmaceutical Joint Stock Company: OPC Pharmaceutical is a pharmaceutical company based in Hanoi, Vietnam

Healthcare Policies and Reimbursement Scenarios

In Vietnam, the Ministry of Health (MOH) and health insurance providers are primarily responsible for the regulation and reimbursement of infectious illness medicines. In general, the coverage offered by health insurance providers determines the reimbursement of infectious illness medications in Vietnam. The specific restrictions and payment amounts may differ based on the insurance coverage and the type of infectious disease being treated.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Infectious Disease Therapeutics Segmentation

By Mode of Treatment (Revenue, USD Billion):

  • Vaccines
  • Drugs

By Applications (Revenue, USD Billion):

  • HIV/AIDS
  • Influenza
  • Hepatitis
  • Malaria
  • Tuberculosis
  • Others

By Disease Type (Revenue, USD Billion):

  • Viral Diseases
  • Bacterial Diseases
  • Fungal Diseases
  • Parasitic Diseases
  • Others

By Target Organism (Revenue, USD Billion):

  • Antibiotics
  • Antivirals
  • Antifungals
  • Anti-Parasitic
  • Others

By End User (Revenue, USD Billion):

  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 14 March 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up